Abstract:Heparin has been known to be a broad-spectrum inhibitor of viral infection for almost 70 years, and it has been used as a medication for almost 90 years due to its anticoagulant effect. This nontoxic biocompatible polymer efficiently binds to many types of viruses and prevents their attachment to cell membranes. However, the anticoagulant properties are limiting their use as an antiviral drug. Many heparin-like compounds have been developed throughout the years; however, the reversible nature of the virus inhibition mechanism has prevented their translation to the clinics. In vivo, such a mechanism requires the unrealistic maintenance of the concentration above the binding constant. Recently, we have shown that the addition of long hydrophobic linkers to heparin-like compounds renders the interaction irreversible while maintaining the low-toxicity and broad-spectrum activity. To date, such hydrophobic linkers have been used to create heparin-like gold nanoparticles and β-cyclodextrins. The former achieves a nanomolar inhibition concentration on a non-biodegradable scaffold. The latter, on a fully biodegradable scaffold, shows only a micromolar inhibition concentration. Here, we report that the addition of hydrophobic linkers to a new type of multifunctional scaffold (dendritic polyglycerol, dPG) creates biocompatible compounds endowed with nanomolar activity. Furthermore, we present an in-depth analysis of the molecular design rules needed to achieve irreversible virus inhibition. The most active compound (dPG-5) showed nanomolar activity against herpes simplex virus 2 (HSV-2) and respiratory syncytial virus (RSV), giving a proof-of-principle for broad-spectrum while keeping low-toxicity. In addition, we demonstrate that the virucidal activity leads to the release of viral DNA upon the interaction between the virus and our polyanionic dendritic polymers. We believe that this paper will be a stepping stone toward the design of a new class of irreversible nontoxic broad-spectrum antivirals.

Supramolecular Architectures of Dendritic Polymers Provide Irreversible Inhibitor to Block Viral Infection

Polyanionic Amphiphilic Dendritic Polyglycerols as Broad-Spectrum Viral Inhibitors with a Virucidal Mechanism

Cooperative Orthogonal Macromolecular Assemblies with Broad Spectrum Antiviral Activity, High Selectivity, and Resistance Mitigation

Reversible rearrangement of the cellular cytoskeleton: A key to the broad-spectrum antiviral activity of novel amphiphilic polymers

Antiviral fibrils of self-assembled peptides with tunable compositions

Star-polymers as potent broad-spectrum extracellular virucidal antivirals

Toward the Prevention of Coronavirus Infection: What Role Can Polymers Play?

Sulfoglycodendron Antivirals with Scalable Architectures and Activities

Antiviral Supramolecular Polymeric Hydrogels by Self-Assembly of Tenofovir-Bearing Peptide Amphiphiles

Ultrashort Peptides for the Self-Assembly of an Antiviral Coating

Antiviral Polymers: A Review

Ultrashort Peptides for the Self‐Assembly of an Antiviral Coating (Adv. Mater. Interfaces 6/2023)

Heteromultivalent Topology-Matched Nanostructures As Potent and Broad-Spectrum Influenza A Virus Inhibitors.

Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection.

An Unexpected Biomaterial Against SARS-CoV-2: Bio-polyphosphate Blocks Binding of the Viral Spike to the Cell Receptor.

Bioengineered self-assembled nanofibrils for high-affinity SARS-CoV-2 capture and neutralization

Dendrimer-Peptide Conjugates for Effective Blockade of the Interactions Between SARS-CoV-2 Spike Protein and Human ACE2 Receptor

Efficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the Avidin-Nucleic-Acid-NanoASsembly

Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2

Combating DC-SIGN-mediated SARS-CoV-2 dissemination by glycan-mimicking polymers

A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13